Results 81 to 90 of about 903 (90)

Allogeneic transplantation for CML in the TKI era: striking the right balance

Nature Reviews Clinical Oncology, 2015
Andrew J Innes, Dragana Milojkovic, Jane F Apperley   +2 more
exaly  

The chromosomes and causation of human cancer and leukemia: XXXVIII. Cytogenetic experience in Ph1-negative chronic myelocytic leukemia (CML)

American Journal of Hematology, 1979
Sei-Ichi Kohno, Syuiti Abe
exaly  

Parthenolide and DMAPT induce cell death in primitive CML cells through reactive oxygen species

Journal of Cellular and Molecular Medicine, 2018
Dafne Moreno-Lorenzana, Peter A Crooks, Mónica L Guzman   +2 more
exaly  

CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction

Journal of Theoretical Biology, 2004
Helen Moore
exaly  

Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells

Cancer Science, 2016
Kazuhito Naka, Cheng Hua Jin, Dong－Hyun Kim   +2 more
exaly  

Arabidopsis Calmodulin-Like Proteins, CML15 and CML16 Possess Biochemical Properties Distinct from Calmodulin and Show Non-overlapping Tissue Expression Patterns

Frontiers in Plant Science, 2017
Kim Munro, Wayne A Snedden, Snedden Wayne A   +2 more
exaly  

Author's Reply: CML as a Second Cancer after CLL

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Prediction of CML contents in the Maillard reaction products for casein-monosaccharides model

Food Chemistry, 2018
Yoonsook Kim, Kwang-Won Lee, Ho-Young Park   +2 more
exaly  

Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65 – a novel Wnt/β-catenin signaling inhibitor

Cancer Letters, 2011
Rina Nagao, Miki Takeuchi, Ruriko Tanaka   +2 more
exaly